Comparing Effectiveness of Physician-assisted Versus Self-assisted Pap Smear Collection

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexFemale
Age21-65
SponsorMorehouse School of Medicine

About this trial

This purpose of this research study is to determine the effectiveness of the Personal Pap Smear Device™ to collect adequate cervical cell samples for cytology examination when compared with the Rover Cervex-Brush (Cervix-Examination Brush).

Eligibility criteria

This trial accepts healthy volunteers

Qualifiers

Adult women, aged 21-65 years old.

Do not have any medical or psychiatric condition affecting the ability to give voluntary informed consent.

Be able to read and understand English

Disqualifiers

Participants currently on menses

Inability to provide Informed Consent

Previous total hysterectomy

History of radiation treatment for cervical cancer

Trial design

Design model

Crossover

Treatments tested in this trial

  • Pap smear collection using the Personal Pap Smear (PPS) Device

    Device

    Diagnostic Test: Use of PPS device to collect cervical cells during pap smear collection.

  • Active Comparator: Pap smear collection using the Rovers Cervex-Brush

    Device

    Diagnostic Test: Use of Rovers Cervex-Brush to collect cervical cells during pap smear collection.

Treatment groups

200 Participants
are divided into 2 treatment groups
Group A: Pap smear collection using the Personal Pap Smear (PPS) DeviceExperimental treatment 1 intervention
Group B: Pap smear collection using the Rovers Cervex-BrushActive comparator 1 intervention

Trial outcomes

Primary outcomes

1

Comparison of the samples for the Predicate Device versus PPS device

Data of Adequate versus Inadequate will be reported to include a positive percent agreement (PPA) defined as PPA= A/(A+C) and the negative percent agreement (NPA) defined as NPA = D/(B+D) along with their 95% confidence bounds using the Clopper-Pearson method.

Time frame
Baseline

Secondary outcomes

1

The Comparison of Cell Types of the PPS Device versus the Predicate Device

The PPS Device and the Predicate Device cell types will be measured against the 2014 Bethesda cytology categories that will be displayed in a 8 x 8 contingency table.

Time frame
Baseline

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

Morehouse School of Medicine

Lead sponsor

GyneConcepts, Inc.

Collaborator